
Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …

A raft of voluntary of charities and community groups are to share £3.5 million in the next financial year as …
Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …
The UK is lagging behind other developed nations when it comes to preventing early deaths from a number of diseases, …
The NHS Commissioning Board has appointed Neil Churchill as the director of Patient Experience. In this new role Churchill will ensure that improving patient …

The government has set up an organisation which will seek to maximise revenue from foreign firms and governments for the …

The volume of GP-prescribed drugs grew by an annual average of 8.4% in the years 1995-2010, according to new government …
The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …

The ABPI has expressed concern at a report by the NHS’s Health and Social Care Information Centre (HSCIC) which suggests …

In a radical change to its modus operandi, NICE has published the first in an ongoing series of assessments of …

The government is attempting to encourage international organisations to help the UK’s efforts to find better treatments for dementia. An …

Eisai has launched its first-in-class epilepsy drug Fycompa in the UK, prior to a roll-out in EU member states including …

People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …

The government has written to NHS prescribing leads telling them they must start to incorporate NICE guidance into their formularies. …

A new survey has revealed that the majority of doctors in the UK are not looking online for information about …